Stimulating Access to Research in Residency (StARR)

促进住院医师研究的机会(StARR)

基本信息

  • 批准号:
    10202706
  • 负责人:
  • 金额:
    $ 27.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Project Summary This is a new institutional application that offers the Medical College of Wisconsin (MCW) a unique opportunity through its Department of Medicine Internal Medicine Residency Program, to recruit, train, and retain promising physician-scientist candidates (2 slots/year) and reverse the troubling losses from the physician-scientist pool. The program will be co-directed by Drs. Widlansky and Eapen, co-directors of the program, are both highly successful physician scientists with strong track records training medical students, residents and fellows. The goal of our program is to provide a versatile, integrated and effective approach for training the next generation of physician scientists in subspecialties of internal medicine that prepare them for a career in academics. We propose an interactive collaborative program designed with specific milestones, training, and metrics for both trainees and mentors. The program will include 5 critical components designed to overcome potential barriers and limitations for launching and sustaining a successful academic research career: i) individualized development plans, ii) dedicated multidisciplinary mentoring team, iii) protected research time, iv) research support including dedicated time for skill building, and v) an environment of integrated clinical and research experiences. Each trainee will be guided by a primary mentor in MCW’s Cardiovascular Center (CVC), the Center for International Blood and Marrow Transplant Research (CIBMTR) or the Division of Hematology-Oncology. An individualized development plan (IDP) will include foundational elements of progressive responsibility, coordination across multiple levels of translation, interactions with mentors and other clinical scientists, peer-to- peer learning opportunities, specific coursework, seminars, and conferences. Trainees will meet with primary mentors weekly to confirm milestones are met, and training in core competencies of ethical conduct of research, grant and manuscript writing, study design and management, reproducibility of data, and communication (mentoring, teamwork, networking, and oral presentation skills). Along with the Directors and two Associate Directors, an Advisory Committee, composed of multi- departmental MCW faculty with extensive experience with career development, leadership, and directing training grants, will provide program oversight and monitor trainee progress. An External Advisory Committee will comprehensively review the training program annually. Overall, the ultimate goal of this training program is to train the next generation of physician-scientists, including underrepresented minorities, by incorporating broad-based, personalized, supportive, and rigorous training opportunities.
项目概要 这是一个新的机构申请,为威斯康星医学院 (MCW) 提供了独特的机会 通过其医学部内科住院医师计划,招募、培训和留住有前途的人 医师-科学家候选人(每年2个名额),并扭转医师-科学家人才库令人不安的损失。 该项目将由该项目的联合主任 Widlansky 和 ​​Eapen 博士共同指导。 成功的医师科学家,在培训医学生、住院医师和研究员方面拥有良好的记录。 我们计划的目标是提供一种多功能、综合且有效的方法来培训下一代 在内科亚专业的医师科学家中,为他们的学术生涯做好准备。 提出一个交互式协作计划,该计划设计有具体的里程碑、培训和指标 该计划将包括 5 个旨在克服潜在障碍的关键组成部分。 启动和维持成功的学术研究生涯的限制和限制:i) 个性化 发展计划,ii) 专门的多学科指导团队,iii) 受保护的研究时间,iv) 研究 支持,包括专门的技能培养时间,以及 v) 综合临床和研究的环境 每位学员将由 MCW 心血管中心 (CVC) 的一位主要导师指导。 国际血液和骨髓移植研究 (CIBMTR) 或血液肿瘤学部门。 个性化发展计划(IDP)将包括渐进责任的基本要素, 跨多个翻译级别的协调、与导师和其他临床科学家的互动、同行之间的互动 同行学习机会、具体课程、研讨会和会议。 每周导师确认达到里程碑,并进行研究道德行为核心能力的培训, 资助和手稿写作、研究设计和管理、数据的可重复性以及沟通 (与董事和两名同事一起提供指导、团队合作、网络和口头表达技巧)。 董事、咨询委员会由具有丰富经验的多部门 MCW 教师组成 职业发展、领导力和指导培训补助金,将提供项目监督和监控学员 外部咨询委员会将每年全面审查培训计划。 该培训计划的最终目标是培训下一代医师科学家,包括 通过纳入基础广泛、个性化、支持性和严格的培训,减少代表性不足的少数群体 机会。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY EAPEN其他文献

MARY EAPEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY EAPEN', 18)}}的其他基金

Medical College of Wisconsin Physician Scientist Immersion Program
威斯康星医学院医师科学家浸入式项目
  • 批准号:
    10591714
  • 财政年份:
    2023
  • 资助金额:
    $ 27.4万
  • 项目类别:
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
I 期临床试验测试使用血小板因子 VIII 的造血干细胞基因治疗通过抑制性抗体安全改善严重甲型血友病止血的可行性
  • 批准号:
    10388261
  • 财政年份:
    2019
  • 资助金额:
    $ 27.4万
  • 项目类别:
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
I 期临床试验测试使用血小板因子 VIII 的造血干细胞基因治疗通过抑制性抗体安全改善严重甲型血友病止血的可行性
  • 批准号:
    10599276
  • 财政年份:
    2019
  • 资助金额:
    $ 27.4万
  • 项目类别:
Cure Sickle Cell
治愈镰状细胞
  • 批准号:
    10270068
  • 财政年份:
    2018
  • 资助金额:
    $ 27.4万
  • 项目类别:
Cure Sickle Cell
治愈镰状细胞
  • 批准号:
    10912972
  • 财政年份:
    2018
  • 资助金额:
    $ 27.4万
  • 项目类别:
Cure Sickle Cell
治愈镰状细胞
  • 批准号:
    10757806
  • 财政年份:
    2018
  • 资助金额:
    $ 27.4万
  • 项目类别:
Cure Sickle Cell
治愈镰状细胞
  • 批准号:
    10934820
  • 财政年份:
    2018
  • 资助金额:
    $ 27.4万
  • 项目类别:
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC
年轻 SCD 患者的造血干细胞移植 - DCC
  • 批准号:
    9127357
  • 财政年份:
    2015
  • 资助金额:
    $ 27.4万
  • 项目类别:
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC
年轻 SCD 患者的造血干细胞移植 - DCC
  • 批准号:
    9532936
  • 财政年份:
    2015
  • 资助金额:
    $ 27.4万
  • 项目类别:
Hematopoietic Stem Cell Transplantation for Young Adults with SCD - DCC
年轻 SCD 患者的造血干细胞移植 - DCC
  • 批准号:
    9324354
  • 财政年份:
    2015
  • 资助金额:
    $ 27.4万
  • 项目类别:

相似海外基金

University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
  • 批准号:
    10557638
  • 财政年份:
    2023
  • 资助金额:
    $ 27.4万
  • 项目类别:
Colorado APS Clinical Center
科罗拉多 APS 临床中心
  • 批准号:
    10645992
  • 财政年份:
    2023
  • 资助金额:
    $ 27.4万
  • 项目类别:
Leadership and Administrative Core
领导和行政核心
  • 批准号:
    10730060
  • 财政年份:
    2023
  • 资助金额:
    $ 27.4万
  • 项目类别:
2/2 Collaborative Union for Cancer Research, Education, and Disparities (CURED)
2/2 癌症研究、教育和差异合作联盟 (CURED)
  • 批准号:
    10762045
  • 财政年份:
    2023
  • 资助金额:
    $ 27.4万
  • 项目类别:
Mentoring in Kidney Health to Improve Equity
肾脏健康指导以提高公平性
  • 批准号:
    10808767
  • 财政年份:
    2023
  • 资助金额:
    $ 27.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了